Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not kidding at all.
The proxi vote was to fix the share structure and provide shares to fill the tanks with inventory.
This did not happen. Instead 111 mill shres were used to pay 1.5 mill in debt.
there needs to be a PUBLIC explanation of this.
One line in the filing saying the LOI dd/financing search prevented closing them.
Thats fine I'm not judging the use of the shares- i will reserve that for the results.
The fact of the matter- CBAI is basically in the same position as they were when the 7bill shares were used and the request for the proxi came out.
There is not an appreciable increase in inventory to justify increasing the o/s by over 200% to pay down 1.5 mill in debt.
Anybody who thinks this can occur , without a MAJOR explanation from CBAI management is delusional.
ALL the shares are used and the pps is hovering at near 2 cents!
Who is kidding who? Sorry, I am a BIG supporter of CBAI/CEO- I hold ALOT of shares.
There is some explain' that needs to be done -- not in a private phone call- in a public stamtent and all the legalese that comes with same.
Or there needs to be another major move by CEO very shortly (which I suspect is actually what is occurring)
AIMHO GLTY/A
I agree, CEO VERY SOON needs to make a statment as to the state of CBAI in relation to the proxi vote.
NO DOUBT ABOUT IT!
AIMHO GLTA/Y
I bought this at 7 - dropped like a rock.
Do you see any signs of a turnaround anytime soon?
TIA GLTY
AGAIN being PRESUMPTOUS IS A BAD THING!
GLTY
By saying one should call the CEO if one has a questions, is being presumptous as to what kind of communication the investor has had with the CEO. Being presumptous is not a good thing.
AGAIN-- THE EXPLANATION NEEDS TO BE PUBLIC SO THE LARGER INVESTMENT COMMUNITY IS COMFORTABLE WITH THE STAtE OF CBAI, SILENCE WILL HAVE A NEGATIVE AFFECT.
It is no more difficult to understand than that.
GLTY
CBAI isnt on the verge of bankruptcy.
CEO used the shares for something fundementaly different than the reason stated fro the need for the proxi.
This cant be left unexplained. PUBLICLY!
GLTY
Thanks for offering the CEO's time.
You miss the point, the explanation needs to be public - so the investment community is comfortable with the state of CBAi.
GLTY
CEO definately has some explaining to do.
I leave it in his hands to decide what the best use of the shares was.
The fact of the matter is there are 250mill shares now outstanding.
Per the proxi the shares were supposed to be used for cash flow positive aquisitions and a cleaned cap structure to ulplist inorder to attract a larger investor base -
They were not used for this-- one line in the filing stating that the financing and the DD on the loi decided to pass , is not going to suffice.
There is no way current organic growth levels will be enough to put meaningful positive pressure on the pps with this many O/S.
110 mill shares were used to pay of 1.5 mill in debt. this needs to be explained.
NO QUESTION ABOUT IT. IT NEEDS TO BE EXPLAINED VERY SOON!
AIMHO GLTY
No,
I don't think - using 100mill shares to satisfy 1.5 mill in debt is relative value.
I was happy that the shares werent used for operations, shows CBAI is starting to get its revenue feet underitself.
There still is ALOT of explaining to as to why he went this direction.
He wont be able to get additioal shares authorized, that s for sure.
So he made a choice with the shares for a reason.
I believe one of two things will happen. Either he will continue to grow organically, which at least for awhile will be find and likely beneficial to investors, as increasing revenue should put a positive pressure on the pps, without negitive share financing pressure. Which should give some nice profit opprotunities for sharholders in at this level.
It would take a long long long time to grow organically into 250 mill shares. So definatley O/S are top heavy v revenue and projected growth.
So I think likely we are going to see shortly -- a MAJOR change to CBAI - either being bought or a merger.
The key from here on out is keeping as many shares you currently hold as possible. You wont keep them all, but at this point CEO's fuduciary duty is to try to protect as many shares as he can for investors if he is seeking to combine CBAI. Or if your not invested, and you think the futre is bright for CBAI, to buy as many cheap shares as you can, before it happens.
If you think CEO made the wrong decision , then short it . If your right were going to sub-penny by the next quarter.
AIMHO GLTY/A
LOL - thats a funny gif Boog.
--- Yes you have been a stalwart here for a long time.
It is definately time to celebrate today. Not quite a fine champange celebration, but definately a glass of CAVA for ~
La marcha hacia el futuro!
GLTY
Yes,
It would have to be a company large enough to give the pps the momentum to alow an uplisting, which is the next phase in the plan
I believe that CCEl is the more natural bridge to this, given the Portnoy's now in charge of it.
GLTY
post-78722
GLTY
GREAT NEWS PAUL!
I see that -- the shares were not used for operations! VERY VERY NICE.
Please tell Matt I said congratulations! Nicely done!
GLTY/A
Yes, the shares clean up long standing obligations. The LOI's have been passed on.
There are no more shares signifigant shares in the treasury.
He doesnt have time to ask for another proxi for a/s. CBAI would go bankrupt waiting for it, and he would never get it.
The die have been cast....with who?... We are all going to find out VERY VERY shortly. You already know who I think it is.
AIMHO GLTY
read the PR - keeping in mind the last five lines of the 10K
------------------------------------------------------------------
S ubsequent to year-end the Company issued 111,194,961 shares resulting in an outstanding share amount of 249,999,364 shares with 250,000,000 authorized. Of those shares issued subsequent to year end, 110,435,264 were issued to debt holders reducing the note balance by $1,564,320.
401(k) Plan Termination
The Company announced it was terminating the 401(k) Plan effective May 6, 2012, and has conformed with the notices required of such termination.
------------------------------------------------------------------
AIMHO GLTA
This filing is likley a pivitol point in the history of CBAI, but it will not be the only and wont be the last. It definatley will make a difference for short term profit opprotunities or lack there of.
CEO has taken alot of heat recently, and while I don not agree with everything he has done and have concerns presently. As we await the filing, It seems he deserves a look at his record.
==
January 2005 – Cord Partners reverse merged into Cord Blood America, Inc. (CBAI), commenced trading on the OTCBB
==
If you look at it from that point thru now, honestly I thinks he has done an Amazing job! Not straying to far off the topic at hand...look at was has changed from the year CBAI went public.
Money for one-It was cheap and easy in 2005. In 2012 its cheap and hard to come buy or has caveats behind it that strangle the borrower if the plan doesnt work out. in 2005 you could buy credit with credit, now its back to 20% down for a homeowner.
Credits Cards are the easy credit access with the caveats. The 0% interest maturity date after a year or so, has hefty penalties for any remaining balance when the agreement matures.
If your talking even farther back than the date above. And your talking this date:
==
January 2003 – Cord Blood America’s original stem cell storage company, Cord Partners, Inc., launched
==
Matt readily admits he started the company with his wife (which is important to remember) and two credit cards. With Matt taking the role as the face of the company and concentrate on the company finacials and stratefgic vision, and his wife behind the curtain concentrating on the product.
When the terms of the credit card matured, it became expensive to hold the debt there, and Wola welcome CBAI and the OTCB and you and me. We bought the credit card debt, on a risk of reward, rather than the fixed interest rate/timeline as the financing companies enjoy i.e. Tangiers etc. Investors get no gurantee except chance on risk, as CBAI does not pay dividens (yet).
It helps to remember what ther vision was when they bought the company. in the first place. The original company was a struggling cord storage company who was a client of their marketing company.
Why buy a struggling company in a struggiling industry? They were in very good position to see the industry was barley formed.
==
CorCell has been banking cord blood since 1996. Meanwhile, the public company Cord Blood America Inc. (Nasdaq OTCBB:CBAI) was formed in Los Angeles in Jan. 2005. CBAI has grown through a series of acquisitions of companies that market family cord blood banking. In each case CBAI has taken over the storage and revenue of the defunct bank's inventory. CorCell was the largest acquisition of CBAI and has retained their operating name.
http://parentsguidecordblood.org/bank/145
===
I can't say what was in their mind, but for the vision statments CEO has given since, I would imagine they saw, correctly, the industry was developing nicely,especially oversees, but there were alot of struggiling companies with some valuable contracts attached to them, that the process of storage was relatively simple and inexpensive. The cost is high for attracting individual , as inexpensive overhead industries tend to have lots of competition.
I believe he thought his marketing background could help control this cost. They saw that the reason the companies were struggiling is not because the industry didnt have an ENOURMOUS potential, that it was more of an economy of scale.
Ray Kroc figured something out when he franchised Mcdonalds, you can make good money selling 200 hundred hamburgers a day at one burger joint in California, or you can make billions, by selling millions a day all over the world. The stem industry in that sense is much like the fast food burger business.
Matt is confident there is a tippping point in inventory in storage where the revenue seriously starts over taking the cost. From his target goals it appears he believes it is somwhere between 100k and 200k in storage. Predominently thru aquisiton or partial purchases of cash struggiling companies inventory at first.
==
•Cord Partners of Los Angeles, founded 2003, was the first cord blood marketing company held by Cord Blood America.
•Cryobank for Oncologic and Reproductive Donors (CORD), a bank with inventory of 750 in Middletown, NY, was acquired in Jan 2006.
•CorCell, inventory of approximately 10,000 held at the lab of Community Blood Services in NJ, was acquired in Oct 2006.
•CureSource, a marketing company based in Charlestown, South Carolina, was acquired in Aug. 2007.
===
Thats what he did. First in America,
===
•In March 2010, CBAI acquired a 51% stake in Stellacure GmbH, a company in Hamburg, Germany, that markets private cord blood banking and uses the laboratory of the German Red Cross (DRK). CBAI also acquired a minority stake in Vidapluscm in Feb 2011, a company that markets for Stellacure in Spain.
•In April 2010, CBAI acquired a 10% stake in China Stem Cells Ltd., and licensed their technology for 8.5% royalties from the subsidiary cord blood bank Well Care Stem Cell Biotech (Liaoning) Co. Ltd.
•CBAI became the owner of BioCells, a family cord blood bank in Argentina, in Sept. 2010.
==
Then all over the world. If you were invested at this time then he used both your and my money to do it(in a round about way). He sold the shares at a discount for millions to people like Tangiers, St George etc. Investors are the ones who bought them from Tangiers. We all had that choice, we new we were buying shares backed by cost not revenue.
It was obvious what he was going to due because he said he was going to do it, and he said what he was going to do with the money.
First he was going to build the storage backbone ~ logistical processing and storage facilities throughout the world. Then he was going to fill the tanks.
He very nicely accomplished the first task, the Chill slowed to a crawl the second. I agree the wait for the tanks to be filled is very frustrating.
What was the cost of the First task? 7Billion discounted shares and a Chill costing millions in real penalties, just to name a few. Was it worth it? From renting storage space to one of the largest storage facilities in the USA, a equity stake in the largest storage facility in the world, and major presence in Europe with a cooperation of the largest blood organization in Europe the German Red Cross, and an even bigger presence in South America home to 1 Billion people. CBAI currently has access to about 3billion people. Another billion and a half are in the Hindi regions where CCEl has affiliates. Hence the attempts purchase of same after the First phase was complete. The knock me down with a feather and the foaming at the mouth event were suppossed to be the same thing- Cash flow positive and the filling of the tanks in one fell swoop, the capstone of the 7billion shares.
He lost! CCEL said NO twice, but didnt close the door. It seems the result of this "failure" was the need to use the rest of the 7 billion shares for operations broght upon the scruitny of the DTCC. CBAI basically hit a brick wall.
IF their is a competency question with the CEO, I belive it would be in this area.
With the question being ~ Why not begin the program of organic growth and burn reduction at this point? And not run the 7 bilion to the end , as we know about 1 billion shares were discounted for financing in about a year. Commonly refered as dilution.
The end result was a CHILL, R/S (100/1), A/S, organic growth.
Was this a CEO misstep? Maybe. Was he trying to screw shareholders at his own expense? No. CBAI was broke.
I was against the proxi and was vocal about it, go back and check. I said then the only way I would support it is if CBAI were broke. They were broke- and I was surprised at the rate of (dilution).
The proxi plan and o/s, a/s ratio was based upon using the shares to purchased inventory. So far there has been no substantive aquisitions to support the proxi.
This will have to change very soon.
If in the next filing there is not considerable increase in revenue and all the shares are used up. Competence will come into question.
If Matt didnt learn alot about the SEC and how it works from the CHILL experience then I think were in trouble. I think the filing will give us a good indication.
If an investors honestly looks at what the CEO has built since 2005, they have to be pleased.
We are now in a situation where an investor, who was a strong advocate of selling the cord business of CCEl to CBAI 1.5 years ago, now is the Board of Directors of that company, with a board dominated by his same desire. What do you think is going to happen?
Thus accomplishing the second part of the plan, filing the tanks. Getting off share financing, and uplisting.
An investor is much like a Fortune Teller. One with money one with words, both try to predict the future based on information from the past and present. Ultimately they are either proven worng, right , or somewhere in the middle. If a Fortune Teller wrong then well:
Sticks and Stones may...... u know the rest.
If an investor is wrong, he loses money. If he is right he makes money. If its somewhere in between he comes ok slightly better or slightly worse depending what side of the between he ends up.
As an investor of CBAI holding LOTS of shares, when I really look back at what has been accomplished over the past seven years, I like my odds.
Investing in CBAI is really like investing in UPS when it was new, with an added long term wharehousing component. Your basically buying a global logistics network, that your banking on will be heavily utilized in the future. The timeframe being driven by the technology ~ a technology still getting its feet under itself, but progressing nicely.
Stem Cells have improved upon Bone Marrow transplants like UPS improved up the post office. Now UPS is an iconic and innovator of global shipping.
If stem technology pans out as the medical revolution, its potential seems, sweeping in an era of Indivdualized Medicine(very important) and humanking continues toward global fluidity,meaning dispersing farther and farther from there immediate birth area. Then there will be a great need for a trusted global deliverer of stems of life that are usable and readily available whereever in the world the patient happens to be. ~ whoever ultimately controls that, will own a Multi Billion Dollar Company. If CBAI can hold on, that might just be you and me.
The time frame? Who Knows. Stem research drives it. One thing for certain it wont be CBAI as long as they are on the OTC. I don't know for certain, but I would imagine CEO is laser focused on getting of this trading board. Our investments will be extremely violatile until then. With the danger of our investments is a share correction around uplisting activities without investors given an opprotunity to take profit from a growing company not pressured by share financing.
The key for current investors is not the share price in the long term, it is the abilty to keep your current shares. I imagine there is going to have to be some sort of a correction in the future. The size of it will determine whether you win or lose, because after the next correction it will be alot more expensive to get in, as the only aceptable reason for a correction would be an uplisting.
Some constantly beat the CEO up over integrity. I have disagreed with him on the timing and ratio of the proxi. When you really look back at the last seven years and what he(and wife) have built, I don't think one can't help but stand up and applaud.
AIMHO GLTA
Clap...Clap..Clap ~ DD does wonders : ) This may help also.
Been buying CBAI ever since the Portnoys took over the CCEL board.
I like the odds the rockets about to blast off. I hope there is a least a hint in the filing.
AIMHO GLTY
------------------------------------------------------------------
SHOULD YOU RELY ON THE MANAGEMENT SLATE TO MAXIMIZE VALUE?
Cryo-Cell recently announced that the Executive Committee of its Board of Directors has authorized the Company's management and financial advisors to explore strategic alternatives to enhance stockholder value, including a possible sale of the Company. Having invested significant percentages of our personal financial resources in Cryo-Cell, we believe that our interests in Cryo-Cell are the same as yours and we are asking ourselves if the timing of this recent announcement is a mere coincidence given the rapidly approaching election?
In evaluating incumbent management’s credibility and commitment to exploring a sale of the Company, please be aware that in 2010, when I introduced DW Healthcare Partners, a private equity healthcare firm, to discuss acquiring Cryo-Cell, Cryo-Cell not only rebuffed DW Healthcare’s offer, but Cryo-Cell’s board of directors refused to even enter into negotiations. We believe DW Healthcare’s publicly issued press release over the PRNewswire on October 15, 2010 said it all:
“[Cryo-Cell’s] board's refusal to engage in discussions regarding our offer raises serious concerns about the board's priorities.”
??-----------------------------------------------------------------
Please see the full press release at: http://www.redorbit.com/news/health/1932351/dwhp_withdraws_second_offer_for_ccel__based_on_boards/.
------------------------------------------------------------------
Furthermore, three members of our slate have backgrounds in investment banking. We believe we are clearly qualified to evaluate the best strategic alternatives for Cryo-Cell, and will do so with the mutual interests of all Cryo-Cell stockholders in mind.
http://www.secinfo.com/d1488v.q27b.htm#1stPage
------------------------------------------------------------------
I agree boog, i think we are in good hands.
I think your right this is the year it goes over the hump, it has to or CBAI wont be around. The fireworks are about to start.
AIMHO GLTY
I think definately have to give CEO kudos for surviving thru the 2009 market correction, they were equating to the great depression. In an indutry that really has learned to crawl yet.
This is a long game here, with the risk being will CBAI be able to survive until the industry takes off. Which most here likley will agree will happen, or we wouldnt be invested. Unless you were trying to flip and got caught, or your shorting the stock.
If so then ~ Caveat Emptor.
It is frustrating not to have sustained profit opprotunities due to share financing, investors have had fair warning as to what was going to happen with the shares. They are investors so they must have bought.
It is time to show some signifigant measurable sustained movement forward
I think tour CEO is competent. Definatley if you think the difference in my investment growing is getting rid of the CEO. If you bring it forward for a sharholder vote, if it makes since I will vote your way.
AIMHO GLTY/A
Why don't you boot him them? Your an investor.
You saw what the Portnoy brothers just did. They were simply investors.
Take a look at what is going on over at cpic. a delisting and investors have a class action suit against the CEO, for basically lying to them. He has resigned.
You have been bringing forth a whole slew of "evidence" for quite sometime as to how crooked or incompetent the CEO is. Either way, there something YOU can do about it.
Why don't you organize the investor revolt. There is alot of examples out there to guide you along.
Put your charges in front of investors at the next shareholder meeting and demand change. If it makes since I will vote your way, and vote to get rid of the CEO.
If it doesnt. Well then at least it will get a fair airing.
Constantly crying the sky is falling, surely isn't helping to get your investment back.
GLTY
It would ~ it would be called accretitive dillution.
A merger with CCEL would cost CBAI sharholders shares.
CBAI hasn't used accretitive dillution yet, all other "dilution" has been share financing there is a BIG difference.
Accretitve dilution we lose shares but the shares gain in value to the combined value of the two companies.
Thats why if a merger happens - you want to have alot of CBAI shares. Even better if you have CCEL also so more or less what u lose in cbai shares you gain back in your ccel shares.
currently for about $1000 you can buy about 50,000 CBAI shares. CCEL closed today @ $2.40/share. Does anyone think they are going to turn 1k into 120,000K? Doubtful. So there would have to be a share correction for a merger to occur ~ in the form of Accretitive dillution.
Whats the alternative? There are already at least 109mill o/s. There is a max of 141 million shares left. .0221 todays close , those shares are worth on the market- $3,116,100.
If CEO uses the remaining shares to share finance for operations while he pursues organic growth, CBAI is going to be broke very soon, because the revenue growth isnt outpacing the % of shares used.
If he doesnt get off share financing very soon, he is dead in the water. He knows more shares will never be authorized.
He has to find alternative financing in a depressed market.
Has CEO been lying about everything? Some think so. I don't. If his intentions were to run a scam. Seems there would be much easier scams to pull off, than collecting stem cells in order to bilk investors.
Is the CEO incompetent? Some say yes. I think we are all about to find out. When the rest of the shares are gone, which at this rate would be by the end of the 3rd 1/4 2012. Thats IT!
CBAI will have to in a signifgantly better financial position, using their own cash for operations. If not its over. The well will have gone dry.
I don't think the CEO has given up. So I think he will use the rest of the 141mill for something signifigant, and it will happen in weeks/months not years.
Why? Because he has to.
IDK if that will involve CCEL or not there seems to be signals pointing in that direction. A point against the scenario is if a merger was coming, CEO likely fiduciary duty to shareholders would to extremely restrict the use of the a/s, this doesnt appear to be occurring.
AIMHO GLTY?A
welcome back DD
see below thanks.
GLTY
I don't have any direct knowledge that a CCEL deal is in the works.
I probably should have qualified my comment more. I apoligize for the confusion.
I do believe a deal is a very real possibility.
CBAI has been mostly silent since the release that they are exploring "strategic alternatives". Recent activities by CCEL, obviously indicate they are going thru a major transition. The CMEX deal or the other 2 LOI's havent closed. At this point, the logical move would be to close one of them, even at a higher than intended purchase price, as it would bring $ cash flow positive, allowing operational share financing to atleast be suspended. The delay in their closure, may suggest a bigger fish has come around, and the intended financing plan for the LOIs has been redirected toward this fish. This would likely occur as a merger, using an Accretitive Dilution strategy.
If this is occurring the most important isssue for CBAI investors is the share ratio.
With the likely goal to end of with a 100 million share company, which was the desired ultimate o/s under the 500/1 r/s proposal. 13-o/s 80 mill a/s . It ended up (obviously) 67 mil or so o/s and approx 150 mill a/s. for 250mill total. Right now there is atleast 109 mill o/s .If the shares are used to the end - a correction likely would be necessary as CBAI will be share heavy for revenue- and projected growth. a combined ccell/cbai could be healthy at 150mill o/s . currently ccell has about 13mill o/s and are in the middle of a mill share buyback.
Ccel has about $7mill in the bank. Plenty of cash flow positive. A combined company likely could finalize the LOIs pretty quickly. The CMEX LOI might become irrelevant. A combined Co. may also be in a position to aquire more than if seperate. Remember, the industry is still very much consolidating, and the name of the game is still inventory. One of the pillars of CEO game plan is to purchase this inventory at a discount from struggiling companies. As the industry develops, this inventory has potential to gain in value. We saw an example of this with the Illinois aquisitions, garnered thru a bankruptcy proceeding.
What interest would CCEL have in a merger?
It would seem CBAI would be a natural fit. They are both in places the other is not. One has major facilities in western usa the other in eastern usa. An affiliates in many different as well as in the same market. Both companies can have expansion and consolidation simultaneously. Could become larger and more efficent at the same time.
Ccel just fired its CEO - for apparently seems incompetance. It took an investor revolt to do it.
Two brother investors David and Mark Portnoy ~ financiers by trade~ are now running Ccel. How long do you think this is going to last?
Their probably qualified short term, but long term they will have to bring in a CEO that is competent within the industry." What better person(s) than the CEO who tried to buy them twice a year or so ago.? With the understanding Mrs. CEO is an very intrical part of the CBAI management group. Matt, as he would tell you focuses on the financing.
The "golden parachute" CEO recently awarded himself that some elude to may play into this type scenario. The Portnoy's of CCEL are financers, so there would be no need to add a third.
The golden parachute may be " a cheaper to keep em move" in a merger negotiation, assuring CEO /wife come as a package.
Both companies definately need to get off the OTB. This may be the best opprotunity for both to do it. CBAI for sure doesnt seem it is going to be able to have the correct balance of revenue v shares to sustain the required pps to uplist. A merger may create the pps conditions enabling a very important uplisting. Money will always be expensive and the pps always unstable until CBAI un-pinks.
IDK if the a MAJOR DEAL with Ccel is in the works, or is even being thought of today. I do know they tried to buy them twice within the past 2 years, as this came out in the CMEX court case.
Below is some info and links that makes me pay attention to a possible CCEL scenario. Investors may do well to pay attention to this also.
CEO knows he cant come back and ask for more shares, and the math doesnt add up to success with the current organic growth rate vs the share burn rate. CEO is a Very Smart man, he very clearly knows this current strategy can last long and wont work. This is a stop gap measure before the fireworks.. Something BIG has to happen SOON.
I hope there is at least a hint in the filing. If the share # 's are high and the revenue is good but not Excellent the pps will sink like a rock. If revenues are Excellent and the shares are under 150mill, may get a nice, at least temporary rise.
I believe the "knock me down with a feather moment" CEO eluded to some time ago, was the attempted CCEl purchases. That "moment" may have come around again(or never really left- just got delayed).
If so, depending on the terms(this is where investors CEO trust level comes in), if your in when it happens, your investment may finally WIN!
I think the CEO is a Very Smart guy, and very much willing to explain himself if an investor takes the effort to call him. I think he is going to put it together, and I am confident the technology is here to stay. Thats why I'm all in.
AIMHO GLTY/A
------------------------------------------------------------------------------------------------------------------------------------
-"Cryo-Cell fiscal 2011 results are indicative of a company that is in the process of making many organizational and operational improvements," stated David Portnoy, Cryo-Cell's Chairman and Co-CEO. "Although the implementation of these steps is still in the early stages, we are encouraged in our belief that our goals will be achieved."
Mark Portnoy, Cryo-Cell's Co-CEO, added, "With the transition of the new Board of Directors last year, the Company made significant changes over the last six months. We are continuing to improve the IT systems and website, and have embarked on a major rebranding/marketing effort. Although these efforts have increased our expenses, we have balanced that somewhat with cost reductions. We feel these are appropriate and necessary investments for the Company's future. In addition, the Company has implemented its previously announced stock repurchase plan, and to date, has repurchased 415,117 shares on the open market and in private transactions."
http://www.marketwatch.com/story/cryo-cell-reports-financial-results-for-fiscal-2011-2012-02-29
http://www.bizjournals.com/tampabay/news/2011/12/12/cryo-cell-strikes-deal-with-bio-stor.html
http://www.bizjournals.com/tampabay/blog/morning-edition/2012/03/cryo-cell-execs-went-looking-for.html
"At first, we were just investors," said Mark Portnoy, recalling how he and his brother had watched the stock market from a very early age. But now that they are running Cryo-Cell and have become immersed in the science and medical potential of stem cells, "it feels good to do good," he said.
They've learned that stem cell transplants are known and accepted treatments for more than 80 diseases. They've come to appreciate the value of an initiative Cryo-Cell launched in 2007, to preserve menstrual stem cells which are being studied as potential treatments for diabetes, breast cancer, heart disease, stroke and autoimmune diseases. David Portnoy now sees Cryo-Cell as a company at the forefront of regenerative medicine
Portnoy, who waged an expensive battle this year as well as in 2007 to gain control of the board, and four others on his slate were elected at the company’s annual shareholder’s meeting on Aug. 25. The new directors are Portnoy, who heads Focus Financial Corp., an investment banking and venture capital firm in Bal Habour; his brother, Mark Portnoy, a former Wall Street trader; Dr. Jonathan Wheeler, an obstetrician/gynecologist; George Gaines, founder and owner of Orrington Advisors, a business consulting firm; and Harold Berger, a certified public accountant.
http://www.bizjournals.com/tampabay/news/2011/08/31/portnoy-group-wins-board-cryo-cell.htm
===============================================================================
http://www.streetinsider.com/Mergers+and+Acquisitions/Cryo-Cell+(CCEL)+Confirms+$1.50Share+Buyout+Offer+from+PE+Group%3B+Rejects+Bid+Saying+Co.+Not+for+Sale+at+This+Time/5962690.html
September 13, 2010 8:04 AM EDT
Cryo-Cell (Nasdaq: CCEL) has just confirmed a receipt of an unsolicited buyout proposal at $1.50/share from a private equity group. The company has rejected the offer, saying that it is not for sale at this time.
===
Interesting deal here. On August 23, 2010 CCEL announced that they had retained Morgan Joseph as their investment bank to “explore strategic alternatives”. On September 23, 2010, they announced that they had received an unsolicited bid from DW Healthcare Partners, a private equity firm for $1.50 a share. This offer was promptly rejected as inadequate. We agree. Out valuation is $3.42 per share.
http://cheapstockinvestor.blogspot.com/2010/09/buy-recommendation-ccelob.html
AIMHO GLTY/A
What you have is a company that has learned shares are serious business.
I think you have a CEO that has heard from investors LOUD & CLEAR they want to see the results from their $ spent, not here about the potential.
And he is working his butt off to acomplish this. I think he has been doing this for alot of years. He is just more focus now than ever before.
And he is working on a MAJOR deal with CCEL.
AIMHO GLTY
There is nothing secretive about it
Every shareholder who invested after the proxi new exactly what the were buying ~ a company that was about to start diluting up to about 350% of its 68mill O/S.
Whoever complains about dilution itself wasnt paying attention when they bought.
Any who were investors prior to the proxi ~ had certainly purchased shares during and even larger dilution, a 7bill dilution. If they didnt know what was happenning they werent paying attention.
CEO has been very clear regarding dilution. He is going to do it.
Dilution in itself is not a bad thing. Unless The Market gets weary of it, or revenues and/or assests do not increase relative to the shares issued.
The 7Billion Share Financing almost killed the company, the Chill was a long and costly event, that still lingers and may be still costing CBAI money. It seems CBAI survived, but it definately should swerve as a wakeup to management, that The Market wont tolerate it again. Has the lesson been learned? The filing will shed some light.
The 7Billion discounted shares also being sold into the market resulted in pushing the pps to sub-penny. The Market wont tolerate this again either.
There are currently approx 109mill o/s - likely is higher by now.
This is approaching a 100% dilution since the beginning of a new round of share financing last year. CBAI has gone thru at least 1/3 of the A/S pending the next filing, in less than a year.
The Market wont tolerate this rapid a share financing without a Signifigant increase invetory and/or revenue (they go hand in hand). Organic growth and cost cutting does not and cannot generated the needed revenue fast enough to justify the rapid share finacing. The only way to achieve the needed inventory/revenue is to buy it at a discount from struggling companies, purchase a larger company with a large inventory (8ok or higher), or merge. Without one of the 3 shortly- CBAI shares will plummett, never to recover under this stock symbol.
If after the next filing there are less than 150 mill o/s shares. Then CBAI could maintain the organic growth path they seem to be on right now. But they would have to leave the remaining a/s in the treasury. If they share financing is being used for operations, then they wont be able not to use the remaining shares, will be forced to seek auth for more -- and the whole 7 billion first dilution cycle will start again. CBAI will never survive this, and it will remain the penny it currently is from now until it goes belly up, or is bought cheap.
The only way this happens is if the majority of investors are post proxi. If the majority of shareholders are pre proxi I doubt they would ever agree to more shares without a complete overhall of management, with a demand the company be sold. To the pre-proxi investor 100 shares of ccel for every 50000 CBAI share, would be better than A/s additional shares allowing CBAI to ween itself to bankruptcy.
Aggressive, or less than ideal terms, seems to have put CBAI into a Qunadry more than once. It definately cant continue much longer.
The company will need to make a choice whether to grow organically as its primary growth strategy, and throw away the key to the remaining shares in the treasury. OR they will need to either finalize one or more of the LOI's, buy signifigant inventory, or Merge.
The 7bill dilution didnt destroy the company, because it was used to build the Global footprint, and the US headquarters, both very important, for CBAI future.
It was time to fill the tanks last year to put the next piece of the puzzle in place, thus justify the proxi with a purchase of 1 of 3 opprotunities to purchase a company which would create a cash flow positive company, thus eliminating the need for share financing for operations giving the pps (and share holder investments) the much needed relief of the negative pressure of discounted shares entering the market. To date this hasnt happened.
The reason have been the chill and a low pps~ preventing quality financing terms for the planned 350% share financing described in the proxi.
The proxi was proposed and voted with the understanding the newly a/s and the r/s were designed to one bring o/s more inline with revenues, in order to attract quality financing. As well as for aquistion of profitable companies and discounted inventory.
Since the stated goal has changed to increased revenue thru organic growth, cost control and reducing burn.
This strategy cannot continue with this apparant rate of share financing. The timelines for necessary benchmarks of success dont coincide. Management has to know this.
Short of requesting additional shares(which I dont' think is their intention),the alternatives would be: to drive the company into the ground. To use the remaining A/S 140mill or less to share finance or Accretitive Dilution purchase a cash flow positive LOI(then would have to greatly reduce cost very quickly). Or Merge thru - which Accretive Dilution would be used towards CBAI. Investors would receive a 1 for X CBAI share of the stronger comapny we merge with. A CBAI investors could only hope the terms would be negotiated favorably.
I would think the biggest concern investors have for the use of the A/S shares is the risk it puts the current shares they hold will permanently be devalued thru another share correction when the 250 mill shares are used up.
I would think pre-proxi current shareholders believe the CEO should view the shares as sacrosant as most probably averaged down and have lost most of the value in their pre-proxi shares. I dont think these shareholders will so much ask anymore as to demand a thourough accounting (which will take many forms) as to the cause, the result, and the state and plan for CBAI relative to the proxi.
The key to investors at this point is to make it very clear there is no tolerence for another share correction, additional authorized shares, or lack of relative value for every A/S share utilized.
An investor cant expect to become an instant millionaire by buying a half million of a companies diluted shares,when they obviously have very limited revenue to justify the dilution.
What they can expect however is the company only use those A/S when they will bring real sustained value to the company,and use them in a way and a timeliness that allows the Market to absorb the positive use of the shares so as to put positive pressue on the pps and bring at least periodic sustained profit opprotunities for investors.
Hopefully the filing is very good news relative to o/s v revenue growth. If not shareholders should begin the process of demanding very tough answers, and very hard inventory numbers from management and an accounting for what has gone on beyond the Chill, and a low pps that is being pushed down unnaturally and indirectly by management.
I am confident in management, and think a giant leap forward for the company is about to happened. I have backed it up with share purchases. If the filings is negative relative to inventory v revenue v shares. I will have to admit my confidence in management to be able to put it together will have become much less sturdy.
All the nuiansces are over, From this filing here on, the only thing that matters to the health of your current shares, and your ability to hold onto your very cheap diluted shares until the industry takes off and CBAI pps explodes turning your half million shares into a fortune you dream of,
Is the use of shares relative to the sustained revenue generated by financing garnered from them.
There is an absoulte opprotunity to increase your current wealth tremendously with your investment in CBAI.
Google sells for approx $500/share. They are in the very lucrative business of delivering instant information to the individual. Lvl2, retail deals, tax service,family connections stock tips, concert tickets, directions, good hospitals, new tharapies...etc. the list is endless.
For the individual this is a very empowering tool, Googles pps reflects this as does their revenue.
What service good possible trump this? In the last your reports of a 95% sucess rate in Spain to bring caustic burned blind patients the return of sight via the use of stem cells.Transplant Doctors are discovering that if the organ donor supplies stem cells along with the organ, it may eliminate the need for expense,forever use of anti-rejection drugs from the receipt. Peyton Manning had stem cells injected into his neck as part of a major neck issue. Several other athletes have used stem cell therapy for other injuries. Doctors have found success in repairing heart tissue from stem cells.
There are currently literally thousands of clinical trials surrounding applications for stem cells due out by 2015. Some I mentined above are just beginning to trickle out. Scientist are discovering - useful stems cells are all over the human body. DR O'Neill adivses the Golden Chalice - replication~ the abilty to transform a stem shell into any living cell desired is not 10years but not 30 years away either.
I would think the one thing more important to an individual than empowering information, is their and loved ones a body free of disease and restrictions, throughout the course of life and the extension of that life. The pps for a company on top of that industry if Googles is 500/share is mind boggling.
All a current investor can ask the CEO once the 250mill A/S are used not have CBAI in a position where there must be a share correction or addition, or stable growth isnt signifigant. If a merger is necessary, and appropriate, it is done in away that puts the current investor in a more positve position than they had at the intitial investment.
I definatlety would rather see CBAI use the A/S to solidify itself finacially(increase inventory) then embark upon a steady cash-rich organic growth, as we come closer to the clinical results due 2015. Which if recent stem success news is any indication, the stem industry should explode, and so should CBAI pps.. IF ... well ..um.. sorry it took so long..u just read the IF.
AIMHO GLTY/A
CEO has not been using Accretitive Dilution. CEO has been using share financing. There is a BIG difference.
Share Financing enters into an interest agrement with an entity in order to obtain cash funds.
These funds can be utilized for buying companies or for ANY other purpose. Discounted shares are then sold into the market buy the finacing entity. Depending on the share financing agreement, the company can either get a great deal or get a very bad deal.
Accretitive Dilution on the other hand, directs a specific number of shares to the shareholders of a particular company. Depending on the relative value of the two companies involved - depends on how many shares are transfered to the stronger company.
Te BIG difference is, with Accrettive dilution the sharholders of the companies involved, know that the amount of dilution is relative to the value of the entities involved. This is a much better deal for shareholders, as they know every new outstanding shares has cooresponding value relative to real assest.
Under Share Fiancing however shares converted into a cash value, then ultimatley sold into the Market dont have an assest value attached to it. If a company using share financing doesnt use the funds to increase assest value, then the shareholder holding shares when the share financing shares enter the Market LOSES real share value.
CBAI has been engaged in Share Financing , NOT Accretitive Dilution.
I would prefer CBAI utilizes Accretitve Dilution rather than Share Financing.
AIMHO GLTY/A
What's Accretive Dilution? And how is CBAI doing this?
Thanks
If CEO is correct that the market values the cords in inventory @ 1k a cord. The Market believes CBAI has approx 30k in storage with 109mill o/s shares.
If this is correct CBAI pps is right in line, it actually would be a undervalued right now.
Obviously if the filing comes out, if there is a signifigant increase in o/s and no indication of more than 30k stems in inventory, the pps will plummet.
If the inventory has increased signifgantly and the shares are about the same- CBAI should have a very nice rise.
If long term investors want to try and get some of their $ back. This may be the opprotunity, depending on what they think the filing is going to say relative to shares v inventory.
Until then IMO its going to stay about right where its at
AIMHO GLTA
the extension is a little concerning- generally for cbai in the past filings after extensions havent been the best news
--- hopefullly this time is different.
AIMHO GLTA
One thing is for certain the filing is due!
Whether its tommorrow or not, it is going to come shortly.
Whats in it is more important than when its presented.
When it comes to the value of our shares:
The revenue v cost is important but less important than inventory v shares. and solving the Quandry is the most important of all.
The expectation is for investors is revenue should be atleast modestly increasing, and the cost revenue percent gap should be widening on the positive side. Those investors concerned about CEO intergrity would likely get alot of that anxiety relived or verified by paying particular attention to the cost expenditures. What direction CBAI's money is being directed, gives and idea if the CEO and team are "in it to win it" for all or just a few at the expense of most.
If the cost v revenue is on the negative side it would bring a question of leadership capabilities as management stated goal was to focus on this over the majority of the filings time period.
The Nevada lab needs to show that it is becoming a signifigant revenue maker. alot of shares were used to finance it - it needs to start paying off. With the understanding that the US storage market will continue to lag beyond the world market for quite some time. Of all the people you know, how many do you really know are private storing? How many however due you know have donated or their children have donated their cords? The money in the US right now is in contractual processing, and in buying inventory from struggiling companies as the industry continues consolidating.
Hopefully placenta processing revenue has grown more signfigantly. Inventory aquisiton primarly come from the affilates organic growth, and thru purchases. By this time the affliates organization should be much more streamlined and effcient. It should reflect in their cost of business which should be decreasing. Inventory aquisition is pending - there needs to be a major aquisition or a major explanation as to why not very shortly. The Chill as a reason is no longer valid.
Their is a Quandry for management that should not be lost on investors regarding aquisition-
One of the stated reason as to why the LOI were not moving forward is due to the low share price. One of Management's reason for delaying the LOI was not to burn thru all the A/S due to share financing with a low pps. However by continuing to share finance for activities other than aquisitions, this continues to unnaturally push down the pps, thus preventing managements stated goal of allwoing the pps to rise based on continued increasing organic growth, to a level that makes aquisition share financing attractive. Managemant has created a negative circle for themselves. A second stated goal by management was to use one of the LOI to become cash flow positive. Just one would accomplish this. However if Managemnt continues share financing for no aquisition activites they never allow the pps it natural positive momentum, preventing a pps attractive enough for acquisitions. This only ends when management runs out of shares, and has to do another share correction. Anyone who believes the pps and the company are to different things just ponder this for a moment.
This quandry cannot continue. If this continues and another correction is needed, investors would object vigoursly and demand management sanctions, as they would have been mislead by management, which would be illegal. The investor actions which would follow would destroy the company.
I believe management understands this and will not let it get to this point.
There has been some talk on the boaed regarding Accretitive Dilution. Which is basically a merger.
Accretitive dilution is only a benefit (it pure capital terms) to the share holders of the stronger of the 2 compaies at the time of aquisition. In simple terms ~ the purchasing company exchanges shares for ownership at a percentage relative to each companies value. Unless your invested in the stroger company, you end up with a negitive equity position at least in the short term. The type of aquisitions CBAI is pursuing would indicate the likelyhood CBAI investors will lose equity if management is using an accretitive dilution strategy.
http://www.ibankingfaq.com/interviewing-technical-questions/mergers-and-acquisitions/what-is-an-accretiondilution-analysis/
http://www.investopedia.com/articles/fundamental-analysis/09/accretion-dilution-analysis-mergers.asp#axzz1qYxVB17C
If this strategy exist in CBAI "strategic alternative" quest, CBAI investors may be helped to pay attention to the activities of CCEL or the past year. Currently as I am sure most here know, they are in the process of buying back shares. There are currently approx 12mill o/s ccel shares. CBAI management originally wanted a 500/1 split and and 80mill a/s. this would have left 13mill o/s post split for CBAI. CBAI tried to purchase CCEL twice a year or so ago. This should not be lost on investors.
_______________________________________________________________
The Cryo-Cell board of directors also authorized management to buy back 1 million shares of the company’s stock. On Dec. 7, the company bought back 383,617 shares of stock at $1.80 a share in a privately negotiated transaction, the filing said.
_______________________________________________________________
Revunue v Cost is important. Inventory v Shares is very important. How managemant is going to break out of their Quandry is the ULITIMATE pivitol choice that will either make or break the company and our investments.
We are all about to find out, but it wont be in this filing, this is just going to give us a good idea of the road were on, or the cliff were about to drive off.
For me? ~ I just bought a WHOLE bunch of new shares. My $ is with Matt, I think he is going to pull it off. If the investors allows themselves a realistice timeframe for the progression of the industry, I believe they will be more confident as to what the CEO is trying to do, and his compentance in being able to get it done.
Remember the only thing has been keeping the pps down for the last 4 years is share financing(dilution), the revenues have been increasing nicely. It is definately time for it to stop, except for the specific use of cash flow positive aquistions and inventories. With out it however CBAI wouldnt have the assests and the position globally it has today. With it it caused the destruction of investor value and a near permanant Chill. The Quandry that must be solved. At a mimmumum CBAI needs to take a long break from the pressures of share finacing prior to all the a/s being used. This would have investors "foaming at the mouth", as the true pps would begin to emerge.
AIMHO GLTA
There are truths as to what you say. I for one am not concerned any longer what the CEO says. I want to SEE the results. The CEO has laid out what appears to be a solid inventory growth plan. Its time to put the plan into action, and fill the tanks.
~~ the time for talk is over - The company will be judged on results from this point forward. Its starts with the next filing.
If those results dont show a substantial increase in inventory relative to A/S shares, then your (and my) shares run the risk of being diluted to the point of no return (meaning another correction would need to take place), if this occurrs CBAI wont have to worry about the future- investor lawsuits will destroy it before it can get there.
--- I have confidence in the CEO that he is the "real deal".
--- and agree with you its time he shows it -- not talks about it.
AIMHO GLTY?A
As Boog would say ~ This rocket is fueled, sitting on the launch pad ~
whether or not it takes off - sits squarely on What have the A/S has been used for? How many have been use? What has been the return on ivestment,for the share financing?
If they have been used for their intended purpose- then shortly we may be taking a trip beyond the moon.
If a large amount has been used for operations. Investors are going to be rightfully so demanding change. Including me.
The clock is about to strike midnight.
AIMHO GLTA
There is 1 thing that matters this week-- the filing
--- when it comes out - what matters is the number of Outstanding Shares VS The number of inventory.
It will either validate the R/S ~ A/S proxi vote
-- or it will suggest there was a different plan for the Proxi than was not being told to the investors. This would be VERY bad.
AIMHO GLTA
It is definately the bewitching hour(week) for CBAI
AIMHO GLTA
and we continue to march (or maybe leap)forward
Study suggests breakthrough in organ transplants
A small pilot study indicates that following up an imperfectly matched organ transplant with an infusion of the donor's stem cells may free recipients from a lifetime of anti-rejection drugs.
http://www.latimes.com/health/la-he-kidney-transplant-stem-cells-20120308,0,6483577.story
Currently:
inventory->pps<------------SHARE FINANCING for operations
What is needed:
INVENTORY--------------->PPS<-share financing for aquisitions
PPS Explosion occurs?:
When operations share financing stops and inventory apporaches 100k
PPS Implosion occurs?:
When share financing continues for operations, and inventory stays below 40k.
Timeframe: End of 1st Quarter.
There is NO WAY this company will attract LONG TERM investors/ QUALITY finanacing as long as there is a concern that the shares an investor purchases today- will be subject to and adjustment (r/s) later. Currently with no appreciable inventory increase and continued share finanacing -- The PPS will never sustain a rise. Once there are 250mill O/S, if inventory isnt over 100k it will be a disaster.
Any investors who believes this situation is good is fooling themselves. Share financing for operations needs to STOP!
NOTHING MORE NOTHING LESS
AIMHO GLTA
There seems to be a whole lot of investors - who dont have the same positive feel I do.
Their interpretation is just as important as mine. Without investor confidence, the OTC CBAI is going to have rough road to travel.
NO KIDDING!
GLTY
Read the most recent filing.
Soon there are going to be 132,000,000 shares outstanding, nearly a 100% increase in the o/s count post r/s.
There are approx 120,000,000 a/s share remaining in the treasury.
The outstanding shares are now top heavy vs inventory and revenue, as compared to industry competitors.
CBAI is now at critical mass.
Either management is going to do what they say they were going to do, use the shares for inventory aquisition. Or they will use the shares for operations
CBAI has about 30k stems in inventory.
China Cord Blood (CO) has approx 73 mill shares outstanding and approx 150 thousand stems in inventory
At the end of last year CO issued approx 13 mill in warrants. prior to warrants issued CO stock was appox $ 4 share, currently CO share pric is approx $3 share.
--- I would say an approx 20% share financing debt put quite a bite of negative pressure on CO share price. This debt financing was used to purchase. In 2/2010 CO paid 20 million for a 20% stake in Shandong Cord Blodd company.
What do you think is going to happen to CBAI share price after a 100% share finacing dilution debt over a 6 month period, if CBAI uses those funds for operations rather than inventory aquisition.
If CBAI doesnt get it financing house in order VERY SOON. You will wish you sold at today's close.
CBAI is running out of options very quickly. Management either dramatically increases inventory by the end of the 1st Q 2012 with the funds from the share financing as laid out in the filing.
Or they continue to burn thru shares funding operations, which ultimately will lead to the demise of CBAI.
RIGHT NOW -- IS CRITICAL MASS FOR CBAI. Either the aquisition game plan needs to be put into action or the share financing needs to stop, there really is no other option.
To have a CBAI with 250million o/s shares and 30k stems in inventory. CBAI would be the laughing stock of the industry, and the logical conclusion would be Managemnet intention the entire time was to use the r/s - a/s shares for operations and options awards rather, rather than the aquisition strategy they were intend for.
If this is the case CEO will have set himself up for lots of legal issues from deceived investors.
I am still on the side that CEO intention is to put the aquisition strategy in place, and CBAI is about to take a giant leap forward in this direction.
AIMHO GLTY
There definately needs to be an accounting of the a/s - and what they have been being used for.
The shares are supposed to be for aquisitions. There needs to be an update regarding this.
One of the reasons why management said they were not going to go for the aquisitions while the pps was this low, was they didnt want to use up the shares, using too many for the aquisitions when the pps is depressed.
No problem with this strategy.
The problem comes in when management uses shares for operations, this share financing skews the pps downward unnaturally.
This puts managements strategy in a catch-22. They want the pps to rise to save shares, but appears are using share financing for operations, which prevents the pps from rising.
In this regard -- the company and the share price are intertwined.
Management needs to either aquire a signfigant amount of inventory very soon-- (the only thing which will permantley raise the pps), as inventory in storage drives valuation of companies in this industry ( this is the backbone of managements growth strategy). Or managment needs to give an accounting of the share financing post r/s and what exactly the debt associated with same was used for.
This needs to happen very soon.
AIMHO GLTA